Valiant Organics Limited
Valiant Organics Limited Fundamental Analysis
Valiant Organics Limited (VALIANTORG.NS) shows weak financial fundamentals with a PE ratio of 24.67, profit margin of 4.50%, and ROE of 4.51%. The company generates $7.4B in annual revenue with weak year-over-year growth of -0.59%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 43.9/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze VALIANTORG.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakVALIANTORG.NS struggles to generate sufficient returns from assets.
Valuation Score
ExcellentVALIANTORG.NS trades at attractive valuation levels.
Growth Score
ModerateVALIANTORG.NS shows steady but slowing expansion.
Financial Health Score
ExcellentVALIANTORG.NS maintains a strong and stable balance sheet.
Profitability Score
WeakVALIANTORG.NS struggles to sustain strong margins.
Key Financial Metrics
Is VALIANTORG.NS Expensive or Cheap?
P/E Ratio
VALIANTORG.NS trades at 24.67 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, VALIANTORG.NS's PEG of 0.01 indicates potential undervaluation.
Price to Book
The market values Valiant Organics Limited at 1.08 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 6.29 times EBITDA. This is generally considered low.
How Well Does VALIANTORG.NS Make Money?
Net Profit Margin
For every $100 in sales, Valiant Organics Limited keeps $4.50 as profit after all expenses.
Operating Margin
Core operations generate 6.56 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $4.51 in profit for every $100 of shareholder equity.
ROA
Valiant Organics Limited generates $2.70 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Valiant Organics Limited produces operating cash flow of $922.34M, showing steady but balanced cash generation.
Free Cash Flow
Valiant Organics Limited generates strong free cash flow of $797.46M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $28.46 in free cash annually.
FCF Yield
VALIANTORG.NS converts 9.73% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
24.67
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.009
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.08
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.11
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.34
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.006
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.05
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How VALIANTORG.NS Stacks Against Its Sector Peers
| Metric | VALIANTORG.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 24.67 | 24.67 | Neutral |
| ROE | 4.51% | 1010.00% | Weak |
| Net Margin | 4.50% | -110830.00% (disorted) | Weak |
| Debt/Equity | 0.34 | 0.50 | Strong (Low Leverage) |
| Current Ratio | 1.01 | 6.08 | Neutral |
| ROA | 2.70% | -6750.00% (disorted) | Weak |
VALIANTORG.NS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Valiant Organics Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-6.24%
Industry Style: Cyclical, Commodity, Value
DecliningEPS CAGR
-102.65%
Industry Style: Cyclical, Commodity, Value
DecliningFCF CAGR
-69.19%
Industry Style: Cyclical, Commodity, Value
Declining